2022 Annual Meeting | P18 - Poster Session 18

Date Thursday 04/07/22

Time 05:30 PM - 06:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Practice, Policy, and Ethics, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), Global Health and Neuroepidemiology, Health Care Disparities, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-oncology, Neuro-ophthalmology/Neuro-otology, Neuro-rehabilitation

CME Available 0.00 CME credit

Program Tracks Diversity, Equity, and Inclusion

Program Materials Program Evaluations

Event Timeline
05:30 PM - 06:30 PM PDT	Abstract	9-001 - Paraneoplastic Stiff Person Syndrome: Persistence of Symptoms is Common Despite Treatment of Underlying Malignancy Alexandra C. Simpson, MD
05:30 PM - 06:30 PM PDT	Abstract	9-002 - Powassan Encephalitis: A Case Report from Long Island, New York, USA Danielle Bazer, DO
05:30 PM - 06:30 PM PDT	Abstract	9-003 - Combined central and peripheral demyelination syndrome after COVID-19 vaccination with brisk response to plasma exchange and steroids William Hoffman, MD
05:30 PM - 06:30 PM PDT	Abstract	9-004 - Characterization of Neurological Morbidity Associated with Anti-Thyroid Antibodies: Hashimoto’s Encephalopathy and Beyond Mark P. Figgie, Jr., MD
05:30 PM - 06:30 PM PDT	Abstract	9-005 - Autonomic dysfunction following COVID-19 infection: an early experience Kamal Shouman, MD
05:30 PM - 06:30 PM PDT	Abstract	9-006 - Mortality Risk Factors in Patients with Diabetic Autonomic Neuropathy: Insights from a Structured Clinical Documentation Toolkit Alexandru C. Barboi, MD
05:30 PM - 06:30 PM PDT	Abstract	9-007 - Mycoplasma Pneumoniae Infection Associated with Autoimmune Small Fiber Neuropathy and Postural Orthostatic Tachycardia Syndrome (POTS) Kamal R. Chemali, MD
05:30 PM - 06:30 PM PDT	Abstract	15-001 - Accuracy of Automated Analyzers for the Estimation of CSF Cell Counts: A Systematic Review and Meta-Analysis Greer Waldrop, MD
05:30 PM - 06:30 PM PDT	Abstract	15-002 - Authorship Diversity in Cochrane Systematic Reviews of Stroke: Inequities in Global Representation Vivek Bhat
05:30 PM - 06:30 PM PDT	Abstract	15-003 - International COVID-19 Vaccine Experience and Perceptions Survey in Patients with Myasthenia Gravis: An Interim Analysis Yingkai Li, MD, PhD
05:30 PM - 06:30 PM PDT	Abstract	15-004 - Quality of Life in Epilepsy patients in India during Covid-19 pandemic. Nirmal Surya, MD, DNB, FAAN
05:30 PM - 06:30 PM PDT	Abstract	15-005 - Socio-epidemiological Factors associated with the Incidence of Cerebrospinal Meningitis in Sub-Saharan Africa Gabriel D. Pinilla Monsalve, MD, MSc
05:30 PM - 06:30 PM PDT	Abstract	3-001 - Learning to PERSEVERE: Feasibility and Efficacy of Peer Mentor Support and Caregiver Education in Lewy Body Dementia Jori Fleisher, MD, MSCE, FAAN
05:30 PM - 06:30 PM PDT	Abstract	3-002 - Digital Driving Metrics Index Early Mobility Declines in Patients At Risk for Alzheimer’s Disease Jennifer Merickel
05:30 PM - 06:30 PM PDT	Abstract	3-003 - Huntingtin gene intermediate alleles influence the progression from Subjective Cognitive Decline to Mild Cognitive Impairment: a 15-year follow-up study Salvatore Mazzeo
05:30 PM - 06:30 PM PDT	Abstract	3-004 - Combination of Antidepressants and Antipsychotics as Novel Treatment Options for Psychosis in Alzheimer’s Disease Peihao Fan, MBBS
05:30 PM - 06:30 PM PDT	Abstract	3-005 - TRAILBLAZER-ALZ 2: A Phase 3 Study to Assess Safety and Efficacy of Donanemab in Early Symptomatic Alzheimer’s Disease Jennifer Zimmer, MD
05:30 PM - 06:30 PM PDT	Abstract	12-001 - DAMS-Net: A Domain Adaptive Lesion Segmentation Framework in Patients with Multiple Sclerosis from Multiple Imaging Centers
05:30 PM - 06:30 PM PDT	Abstract	12-002 - Social Networks in Pediatric-Onset Multiple Sclerosis are Associated with Less Negative Peer Pressure Micky K. Bacchus
05:30 PM - 06:30 PM PDT	Abstract	12-003 - haMSter: a Smartphone Application for Remote Patient Monitoring Patrick Altmann
05:30 PM - 06:30 PM PDT	Abstract	12-004 - Digital Performance Measures Show Sensitivity to Demographic and Disease Characteristics in a Multiple Sclerosis Cohort Utilizing the MS Care Connect Mobile App in a Real-world Setting Ryan Metzger, PhD
05:30 PM - 06:30 PM PDT	Abstract	12-005 - User Perspectives on a Digital Therapeutic for Major Depressive Disorder in Multiple Sclerosis Patients: A Qualitative Study Gina Kackloudis, Other
05:30 PM - 06:30 PM PDT	Abstract	12-006 - Reliability of Mobile Video Oculography in a prospective cohort of MS patients Mikael Cohen
05:30 PM - 06:30 PM PDT	Abstract	12-007 - TELE MS: A Randomized Controlled Trial Investigating Remote Visits in People with Multiple Sclerosis Patrick Altmann
05:30 PM - 06:30 PM PDT	Abstract	12-008 - Use of MyChart Messages and Telephone Calls in Patients with Multiple Sclerosis at an Academic Medical Center Caralynn Li, DO
05:30 PM - 06:30 PM PDT	Abstract	12-009 - Evaluating Telemedicine Care in Patients with Neuroimmunological Disorders via a Questionnaire Based Survey Huiam Mubarak, MD
05:30 PM - 06:30 PM PDT	Abstract	12-010 - Relationship of Superficial White Matter Integrity and Cognition in Early MS: A Machine Learning Study Korhan Buyukturkoglu, PhD
05:30 PM - 06:30 PM PDT	Abstract	6-001 - Pooled Safety Data from the Risdiplam Clinical Trial Development Program Basil T. Darras, MD
05:30 PM - 06:30 PM PDT	Abstract	6-002 - Real-world Outcomes of Nusinersen Alone and Onasemnogene Abeparvovec (OA) Alone or with Prior Nusinersen in Pediatric Patients with Spinal Muscular Atrophy (SMA): Interim Analysis of a US Retrospective Chart Review Study
05:30 PM - 06:30 PM PDT	Abstract	6-003 - Baseline Characteristics and Initial Safety Results in RESPOND: A Phase 4 Study of Nusinersen in Children with Spinal Muscular Atrophy (SMA) Who Received Onasemnogene Abeparvovec John Brandsema, MD
05:30 PM - 06:30 PM PDT	Abstract	6-004 - A Rare Case of Congenital Myasthenia Syndrome 11 Caused by a Novel Mutation in RAPSN Diagnosed with Rapid Whole Genome Sequencing (rWGS). Graham K. Reid, DO
05:30 PM - 06:30 PM PDT	Abstract	7-001 - Teleintervention for Persisting Symptoms Post-Acute COVID-19 Illness Using Transcranial Direct Current Stimulation (tDCS) Tehila Eilam-Stock, PhD
05:30 PM - 06:30 PM PDT	Abstract	7-002 - Visual Field Defect Rehabilitation through Visual Restoration Therapy Lakshmanan Sankaranarayanan, Sr.
05:30 PM - 06:30 PM PDT	Abstract	7-003 - Treating word finding difficulty in multiple sclerosis using high-definition transcranial direct current stimulation targeting the pre-Supplementary Motor Area Hsueh-Sheng Chiang, MD, PhD
05:30 PM - 06:30 PM PDT	Abstract	7-004 - Application of Principal Component and Discriminant Analyses on Hippocampal Neuromodulation During a Direct Reach Task Richard Lee
05:30 PM - 06:30 PM PDT	Abstract	7-005 - Regaining control of movement following a spinal cord injury using Epidural Electrical Stimulation coupled with Task Specific Training
05:30 PM - 06:30 PM PDT	Abstract	7-006 - A Teleintervention Program for Multiple Sclerosis (MS) Mobility: Exercise with Transcranial Direct Current Stimulation (tDCS) Giuseppina Pilloni, PhD
05:30 PM - 06:30 PM PDT	Abstract	1-001 - Patient Satisfaction of Teleneurology during COVID-19 Pandemic in Detroit Bowen Song, MD
05:30 PM - 06:30 PM PDT	Abstract	1-002 - Neurology Resident Burnout and Wellness: A Quality Assessment Inventory Tool Daniel M. Oh, MD
05:30 PM - 06:30 PM PDT	Abstract	1-003 - Improving Seizure Management through Interprofessional Collaboration Michael Chang, DO
05:30 PM - 06:30 PM PDT	Abstract	1-004 - Assessing the DEI needs of an Academic Neurology Department Sonia Kaur Singh, MD
05:30 PM - 06:30 PM PDT	Abstract	10-001 - Effects of an Evidence-Based Continuous EEG Triage Protocol on Seizure Detection in Hospitalized Adults: A Quality Improvement Analysis Brent Jacobus II, MD
05:30 PM - 06:30 PM PDT	Abstract	10-002 - A Case Report of Second Degree Heart Block and Sinus Pauses after VNS Placement in Refractory Epilepsy Hongxuyang Yu, MD
05:30 PM - 06:30 PM PDT	Abstract	10-003 - Trends in Antiseizure Medication Fills and Cost in Medicare Beneficiaries with Epilepsy Samuel W. Terman, MD
05:30 PM - 06:30 PM PDT	Abstract	10-004 - How Long is a Piece of String? A Retrospective Study of the Correlation Between Length of Stay in Epilepsy Monitoring Unit and Diagnostic Yield Mohammad Hijaz Adenan, MBBS
05:30 PM - 06:30 PM PDT	Abstract	10-005 - An Online, Interactive, Self-Paced, Case-Based Clinical Neurophysiology Curriculum for Neurology Residents Valerie Jeanneret Lopez, MD
05:30 PM - 06:30 PM PDT	Abstract	10-006 - Petechiae: An Atypical Initial Presentation of Seizure Shivanee Sodani, MBBS
05:30 PM - 06:30 PM PDT	Abstract	10-007 - Serving Los Angeles County Patients with Teleneurology, A Clinical Tool Here to Stay Bo C. Leung, MD
05:30 PM - 06:30 PM PDT	Abstract	4-001 - Disseminated Cytomegalovirus Infection with Meningoencephalitis in an Immunosuppressed Renal Transplant Patient Jaspreet Johal, MD
05:30 PM - 06:30 PM PDT	Abstract	4-002 - Nocardia Spinal Abscess in the Immunocompetent Patient Jennifer H. Newman, MD
05:30 PM - 06:30 PM PDT	Abstract	4-003 - Central Nervous System Tuberculosis with SARS-CoV-2 Infection: A Short Case-series from Sri Lanka Shanindra De Alwis, MD, MBBS
05:30 PM - 06:30 PM PDT	Abstract	4-004 - To Report A Rare Case of Focal Cranial Nerve and Long Tract Neurologic Deficits associated with Legionnaire's disease Arshdeep Kaur, MD
05:30 PM - 06:30 PM PDT	Abstract	4-005 - Restoring Levels of a Tumor Suppressor to Treat Glioblastoma using an RNA Therapeutic Strategy Rohan Rao, MD
05:30 PM - 06:30 PM PDT	Abstract	13-001 - Feeding tube dependence among older stroke patients with feeding tubes Corey R. Fehnel, MD, FAAN
05:30 PM - 06:30 PM PDT	Abstract	13-002 - Association Between Mean Platelet Volume And Severity Of Acute Ischaemic Stroke Assessed By Modified Rankin Scale Dinesh M. Chaudhari, DNB
05:30 PM - 06:30 PM PDT	Abstract	13-003 - Closing Gaps in Care of Patients with Embolic Stroke of Unknown Source: A Multi-disciplinary approach Lamya Ibrahim, MD, MBBS
05:30 PM - 06:30 PM PDT	Abstract	13-004 - Acute Pain: A Consideration in Blood Pressure Management in Acute Ischemic Stroke in the Sickle Cell Patient Joseph Frazee, DO
05:30 PM - 06:30 PM PDT	Abstract	13-005 - Pediatric Cerebral Infarction associated with recent SARS-CoV-2 mild infection treated with intravenous thrombolysis and endovascular thrombectomy Luis G. Manrique, MD
05:30 PM - 06:30 PM PDT	Abstract	13-006 - Neuroimaging in COVID-19 Patients on Mechanical Ventilation Receiving Sedation: Insight Beyond Diagnosis Saman Fatima, MD
05:30 PM - 06:30 PM PDT	Abstract	13-007 - Cerebrovascular Manifestations of COVID-19 in Young Adults Pranusha Pinna, DO
05:30 PM - 06:30 PM PDT	Abstract	13-008 - Patterns of Seeking Emergent Stroke Care During the COVID -19 Pandemic: A Nebraska Stroke Center Perspective Mohammad Dibs, MD
05:30 PM - 06:30 PM PDT	Abstract	13-009 - Descriptive Analysis of Acute Ischemic Stroke in COVID-19 Patients Through The Course of COVID-19 Pandemic Jay L. Liu, DO
05:30 PM - 06:30 PM PDT	Abstract	13-010 - Acute stroke patients with low NIHSS did not delay hospital presentation during COVID Ali E. Kaabi, MD
05:30 PM - 06:30 PM PDT	Abstract	5-001 - A systematic review of the spectrum and prevalence of non-motor symptoms in adults with progressive cerebellar ataxias Naveed Malek, MD
05:30 PM - 06:30 PM PDT	Abstract	5-002 - Tremor in Spinocerebellar Ataxia 12 (SCA12): Clinical and Electrophysiological Perspective Achal K. Srivastava, MD, FAAN
05:30 PM - 06:30 PM PDT	Abstract	5-003 - Acute Cerebellar Ataxia after COVID-19 Infection in a 5-year-old Boy. Kimberly O'Neill, MD
05:30 PM - 06:30 PM PDT	Abstract	5-004 - Unusual Presentation of Self Limiting Neonatal Seizures Along with Other Neurological Manifestations in Siblings Diagnosed with Spinocerebellar Ataxia Type 8 (SCA 8) Shrikant Mishra, MD
05:30 PM - 06:30 PM PDT	Abstract	5-005 - Progressive Ataxia and Palatal Tremor with MRI Evidence of Hypertrophic Olivary Degeneration Jennifer Hislop, MD
05:30 PM - 06:30 PM PDT	Abstract	5-006 - Cerebellar Fit in an Adult with Chiari II Malformation Austin Mefford
05:30 PM - 06:30 PM PDT	Abstract	5-007 - Social media consumption in adolescents with tics Jessica Frey, MD
05:30 PM - 06:30 PM PDT	Abstract	5-008 - Functional Tic Disorders in Children during the COVID-19 Pandemic Marisela E. Dy-Hollins, MD, MSCR, FAAN
05:30 PM - 06:30 PM PDT	Abstract	2-001 - The Impact of a Portable Artificial Vision Device (OrCam Read) on Vision-Related Quality-of-Life in Patients with Primary Brain Tumors and Low Vision Tanvi Chokshi
05:30 PM - 06:30 PM PDT	Abstract	2-002 - An Interprofessional Residency Education and Utilization of the Phone-adapted Panoptic Ophthalmoscope Lauryn Currens, MD
05:30 PM - 06:30 PM PDT	Abstract	2-003 - A Sneak into the science of the Sneaker colour- Is it truly related to Cerebral Dominance? Harini Pavuluri
05:30 PM - 06:30 PM PDT	Abstract	2-004 - Association Between COVID-19 Vaccination and Optic Neuritis in Adults: A Vaccine Adverse Event Reporting System (VAERS) Study Mustafa Jaffry
05:30 PM - 06:30 PM PDT	Abstract	2-005 - Vision-Specific Quality of Life in Patients with Post-Acute Sequelae of COVID-19 (PASC) Laura J. Balcer, MD, MSCE, FAAN
05:30 PM - 06:30 PM PDT	Abstract	11-001 - Attitudes, Beliefs and Experiences of an Academic Neurology Department Regarding Systemic Racism: University of Kentucky Neurology Residency Study Thien Nguyen, MD
05:30 PM - 06:30 PM PDT	Abstract	11-002 - Trends in Diversity at a Single US Adult Neurology Residency Program Keiko A. Fukuda, MD
05:30 PM - 06:30 PM PDT	Abstract	11-003 - The Diversity of Graduate Medical Education Leadership in Neurology Morgan C. Jordan, DO
05:30 PM - 06:30 PM PDT	Abstract	11-004 - Socioeconomic Bias in Ordering Toxicology Screens in Patients with an Acute Stroke Fady Mousa-Ibrahim, DO
05:30 PM - 06:30 PM PDT	Abstract	11-005 - Can You See Me Now?: Understanding Health Outcomes in Telehealth Among Seniors Christine Petit-Frere, MD
05:30 PM - 06:30 PM PDT	Abstract	11-006 - Pediatric Neurology Patient Disparities in Use of and Access to Rapid Telehealth Implementation during the COVID-19 Pandemic Lindsey Morgan, MD
05:30 PM - 06:30 PM PDT	Abstract	11-007 - Reassessing the Geographical Distribution of Neurologists in the United States Kyra Curtis, MD
05:30 PM - 06:30 PM PDT	Abstract	11-008 - Measuring Ambulatory Neurologic Health Disparities with the Axon Registry Richard T. Benson, MD, PhD, FAAN
05:30 PM - 06:30 PM PDT	Abstract	11-009 - Tightening up Acute Stroke Care in the Stroke Belt with Telestroke Theresa B. Sevilis, DO, FAAN

Faculty Disclosures
Sanjay P. Singh, MD, FAAN	Dr. Singh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK LIFE. Dr. Singh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NEURELIS.
Clara Chu	Ms. Chu has nothing to disclose.
Dawn Brooks	No disclosure on file
Shanindra De Alwis, MD, MBBS	Dr. De Alwis has nothing to disclose.
Soma Sengupta, MD, PhD, FAAN	Dr. Sengupta has received personal compensation in the range of $0-$499 for serving as a Consultant for Novocure. The institution of Dr. Sengupta has received research support from Harold C. Schott Endowment. Dr. Sengupta has received intellectual property interests from a discovery or technology relating to health care.
Bruce A. Chase, PhD	Dr. Chase has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nebraska Academy of Sciences.
Timothy J. Ainger, PhD	Dr. Ainger has nothing to disclose.
Claire Riley, MD, FAAN	Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viracta. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
	No disclosure on file
Trishna Kantamneni, MBBS	Dr. Kantamneni has nothing to disclose.
Deepak Reddy, MD	Dr. Reddy has nothing to disclose.
Luis G. Manrique, MD	Dr. Manrique has nothing to disclose.
Prashant K. Rai, MD	Dr. Rai has nothing to disclose.
Mustafa Jaffry	Mr. Jaffry has nothing to disclose.
Muruvet Elkay, MD	Dr. Elkay has nothing to disclose.
Peihao Fan, MBBS	Mr. Fan has nothing to disclose.
Jennifer S. Hui, MD	Dr. Hui has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Dr. Hui has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. The institution of Dr. Hui has received research support from Roche. The institution of Dr. Hui has received research support from Abbvie. Dr. Hui has received personal compensation in the range of $500-$4,999 for serving as a Roundtable speaker with Medscape .
Carla Kim	No disclosure on file
Ram Mohan R. Sankaraneni, MD, FANA, FAES, FAAN	Dr. Sankaraneni has nothing to disclose.
Khawla M. Abusamra, MBBS	Dr. Abusamra has nothing to disclose.
Tzu-ying Chuang, MD, PhD	Dr. Chuang has nothing to disclose.
Aimee Borazanci, MD	No disclosure on file
Paula R. Clemens, MD	The institution of Dr. Clemens has received research support from NS Pharma. The institution of Dr. Clemens has received research support from ReveraGen. The institution of Dr. Clemens has received research support from Amicus. The institution of Dr. Clemens has received research support from Sanofi. The institution of Dr. Clemens has received research support from Spark. The institution of Dr. Clemens has received research support from NIH. The institution of Dr. Clemens has received research support from MDA. The institution of Dr. Clemens has received research support from FDA.
Anusha Mangalampalli, MD	Dr. Mangalampalli has nothing to disclose.
Anneke Van Der Walt, MD	Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Van Der Walt has received research support from NHMRC Australia. The institution of Dr. Van Der Walt has received research support from MSRA. The institution of Dr. Van Der Walt has received research support from Roche.
Thy Nguyen, MD	Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ArgenX. Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Nguyen has received publishing royalties from a publication relating to health care.
Shashwat Pokharel, MBBS	Dr. Pokharel has nothing to disclose.
Harshad Ladha, MD	Dr. Ladha has nothing to disclose.
Rohit A. Marawar, MD, FAAN	Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. The institution of Dr. Marawar has received research support from Catalyst Pharma.
Kiran M. Kanth, MD	Dr. Kanth has nothing to disclose.
Zahari Tchopev, MD	Dr. Tchopev has nothing to disclose.
Angela Paradis	Angela Paradis has received personal compensation for serving as an employee of Biogen. An immediate family member of Angela Paradis has received personal compensation for serving as an employee of Biogen. Angela Paradis has received stock or an ownership interest from Biogen. An immediate family member of Angela Paradis has received stock or an ownership interest from Biogen.
Sandeep Kumar, MD	Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for CRICO.
Roopa Rajan	Roopa Rajan has received research support from DBT. Roopa Rajan has received research support from DST-SERB. The institution of Roopa Rajan has received research support from Michael J Fox Foundaton.
Chun Chieh Lin, PhD	The institution of Chun Chieh Lin has received research support from AAN.
Craig McDonald, MD	Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Dr. McDonald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Capricor Therapeutics. Dr. McDonald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catabasis. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epirium Bio. Dr. McDonald has received personal compensation in the range of $0-$499 for serving as a Consultant for Italfarmaco. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Santhera Pharmaceuticals. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis Pharmaceuticals. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Santhera Pharmaceuticals. The institution of Dr. McDonald has received research support from Sarepta Therapeutics. The institution of Dr. McDonald has received research support from PTC Therapeutics. The institution of Dr. McDonald has received research support from Santhera Pharmaceuticals. The institution of Dr. McDonald has received research support from Astellas. The institution of Dr. McDonald has received research support from Capricor Therapeutics. The institution of Dr. McDonald has received research support from Catabasis. The institution of Dr. McDonald has received research support from Epirium Bio. The institution of Dr. McDonald has received research support from Italfarmaco. Dr. McDonald has received research support from NS Pharma. The institution of Dr. McDonald has received research support from Pfizer. The institution of Dr. McDonald has received research support from NIH (NINDS). The institution of Dr. McDonald has received research support from NIDILRR. The institution of Dr. McDonald has received research support from Department of Defense. The institution of Dr. McDonald has received research support from Parent Project Muscular Dystrophy. The institution of Dr. McDonald has received research support from Muscular Dystrophy Association. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Member National Advisory Board for Medical Rehabilitation Research with NIH.
Brenda Banwell, MD, FAAN	Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Robert A. Sweet	Robert A. Sweet has nothing to disclose.
Kamal Shouman, MD	The institution of Dr. Shouman has received research support from dysautonomia international.
Maysaa M. Basha, MD	Dr. Basha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai.
Sandra P. Reyna, MD	Dr. Reyna has received personal compensation for serving as an employee of Novartis Gene Therapies.
Michael J. Schneck, MD, FAAN	An immediate family member of Dr. Schneck has received personal compensation for serving as an employee of Cellcarta. Dr. Schneck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HLT Medical. Dr. Schneck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miscellaneous legal firms. Dr. Schneck has stock in Baxter Labs. The institution of Dr. Schneck has received research support from NIH.
Dinesh M. Chaudhari, DNB	Dr. Chaudhari has nothing to disclose.
Julie A. Parsons, MD	Dr. Parsons has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenex. The institution of Dr. Parsons has received research support from AveXis. The institution of Dr. Parsons has received research support from Biogen. The institution of Dr. Parsons has received research support from Scholar Rock. The institution of Dr. Parsons has received research support from Biohaven. The institution of Dr. Parsons has received research support from PTC Therapeutics. The institution of Dr. Parsons has received research support from Novartis.
Mohammed N. Zaman, DO	Dr. Zaman has nothing to disclose.
Guillaume Lamotte, MD	Dr. Lamotte has nothing to disclose.
Alena Makarova, MD	Dr. Makarova has nothing to disclose.
Greer Waldrop, MD	Dr. Waldrop has nothing to disclose.
Jeremy K. Cutsforth-Gregory, MD, FAAN	Dr. Cutsforth-Gregory has received publishing royalties from a publication relating to health care.
Chantale O. Branson, MD, MSCR, FAAN	Dr. Branson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus.
Mohammad Jamil Ahmad, MD	Dr. Ahmad has nothing to disclose.
Thomas G. Devlin, MD, PhD	Dr. Devlin has received personal compensation for serving as an employee of Neuroscience Innovation Foundation. Dr. Devlin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Nova Signal. Dr. Devlin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Devlin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Devlin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Devlin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viz,ai. Dr. Devlin has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Neuroscience Innovation Foundation. Dr. Devlin has stock in Nova Signal. Dr. Devlin has stock in Viz.ai. The institution of Dr. Devlin has received research support from Viz.ai. Dr. Devlin has received research support from Nova Signal. Dr. Devlin has received intellectual property interests from a discovery or technology relating to health care.
Lindsey Morgan, MD	The institution of Dr. Morgan has received research support from NIH. The institution of Dr. Morgan has received research support from PERF.
John R. Sims, MD	Dr. Sims has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Sims has stock in Eli Lilly and Company.
Hsueh-Sheng Chiang, MD, PhD	The institution of Dr. Chiang has received research support from NIH/NIDCD. The institution of Dr. Chiang has received research support from Texas Alzheimer's Research and Care Consortium.
Stephen P. Klaus, MB, BCh, BAO, MSc	Dr. Klaus has nothing to disclose.
Gabriel Bsteh, MD	Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene-BMS. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme.
Anne C. Van Cott, MD, FAAN	Dr. Van Cott has nothing to disclose.
Hesham A. Abboud, MD	Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. Dr. Abboud has received publishing royalties from a publication relating to health care.
Paola Sandroni, MD, PhD, FAAN	Dr. Sandroni has nothing to disclose.
John H. Sladky, MD, FAAN	Dr. Sladky has nothing to disclose.
Mohammad Hijaz Adenan, MBBS	Dr. Adenan has nothing to disclose.
Bowen Song, MD	Mr. Song has nothing to disclose.
Jee-young Han, MD	Dr. Han has nothing to disclose.
Hannah M. Kelly	Ms. Kelly has nothing to disclose.
Ram N. Narayan, MD	Dr. Narayan has nothing to disclose.
Danielle Bazer, DO	Dr. Bazer has nothing to disclose.
Jeremiah M. Scharf, MD, PhD	The institution of Dr. Scharf has received research support from the TLC Foundation for Body-Focused Repetitive Behaviors. Dr. Scharf has received personal compensation in the range of $500-$4,999 for serving as a Speaker for a TAA/CDC Family Day Symposium with the Tourette Association of America. Dr. Scharf has a non-compensated relationship as a Scientific Advisory Board Member with the Tourette Association of America that is relevant to AAN interests or activities.
Ivan Da Silva, MD	Dr. Da Silva has nothing to disclose.
Nicholas Deconinck	Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for avexis. Nicholas Deconinck has received publishing royalties from a publication relating to health care.
Hussam A. Yacoub, DO	Dr. Yacoub has nothing to disclose.
Bo C. Leung, MD	Dr. Leung has nothing to disclose.
Robyn J. Wolintz, MD	Dr. Wolintz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Wolintz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme.
Agnelio S. Cardentey, MD	Dr. Cardentey has nothing to disclose.
Marisela E. Dy-Hollins, MD, MSCR, FAAN	The institution of Dr. Dy-Hollins has received research support from CNCDP-K12.
John Hart, MD	The institution of Dr. Hart has received research support from Department of Defense.
Sherline Sauveur, NP	Mrs. Sauveur has received personal compensation for serving as an employee of Morehouse School of Medicine.
Jennifer Zimmer, MD	Dr. Zimmer has received personal compensation for serving as an employee of Eli Lilly & Company. Dr. Zimmer has stock in Eli Lilly & Company.
Tanvi Chokshi	Miss Chokshi has nothing to disclose.
Amna Sohail, MD	Dr. Sohail has nothing to disclose.
Ramiro G. Castro Apolo, MD	Dr. Castro Apolo has nothing to disclose.
Laura A. Kalayjian, MD	The institution of Dr. Kalayjian has received research support from NIH.
Nishanth R. Subash	Mr. Subash has nothing to disclose.
Giuseppina Pilloni, PhD	Dr. Pilloni has nothing to disclose.
Laura J. Wu, MD, PhD	Dr. Wu has nothing to disclose.
Shahar Shelly, MD	Dr. Shelly has nothing to disclose.
Sudheer Pachipala	Sudheer Pachipala has nothing to disclose.
Jaspreet Johal, MD	Dr. Johal has nothing to disclose.
Payal B. Patel, MD	The institution of Dr. Patel has received research support from National Institute of Health. The institution of Dr. Patel has received research support from AHRQ. Dr. Patel has received personal compensation in the range of $0-$499 for serving as a Author with MedLink Neurology.
Alexandru C. Barboi, MD	Dr. Barboi has nothing to disclose.
Irene Malaty, MD, FAAN	Dr. Malaty has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Neuroderm. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Cleveland Clinic. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to AAN interests or activities.
Shawna W. Benard, MD	Dr. Benard has nothing to disclose.
Sujata P. Thawani, MD	Dr. Thawani has nothing to disclose.
Panayiotis Mitsias, MD	Dr. Mitsias has nothing to disclose.
Hasmik Amirjanyan, MD	Dr. Amirjanyan has nothing to disclose.
Christopher Richardson	Mr. Richardson has nothing to disclose.
Lauryn Currens, MD	Dr. Currens has nothing to disclose.
Nizar Souayah, MD, FAAN	Dr. Souayah has received publishing royalties from a publication relating to health care.
Paulus S. Rommer	Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for celgene. The institution of Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for merck. Dr. Rommer has received personal compensation in the range of $0-$499 for serving as a Consultant for sanofi. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sandoz. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for almirall. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Dr. Rommer has received research support from merck. The institution of Dr. Rommer has received research support from roche. The institution of Dr. Rommer has received research support from amicus. The institution of Dr. Rommer has received research support from biogen.
Wendy S. Vargas, MD	Dr. Vargas has received personal compensation for serving as an employee of Sanofi. The institution of Dr. Vargas has received research support from NICHD.
William P. Cheshire, Jr., MD, FAAN	Dr. Cheshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for oxford university press. Dr. Cheshire has a non-compensated relationship as a Associate Editor with Clinical Autonomic Research that is relevant to AAN interests or activities.
Lakshmi N. Ranganathan, MD, FAAN	Dr. Ranganathan has nothing to disclose.
Spencer Hutto, MD	Dr. Hutto has nothing to disclose.
Kathleen C. Somera-Molina, PhD	Dr. Somera-Molina has received personal compensation for serving as an employee of Biogen. Dr. Somera-Molina has received stock or an ownership interest from Biogen.
Erika T. Marulanda, MD, FAAN	Dr. Marulanda-Londono has nothing to disclose.
Matthew Orwitz, MD	Dr. Orwitz has nothing to disclose.
Phillip A. Low, MD, FAAN	Dr. Low has nothing to disclose.
Hasnain Arshad, MD	Dr. Arshad has nothing to disclose.
John F. Foley, MD, FAAN	The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Foley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Foley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Foley has stock in InterPRO Bioscience. The institution of Dr. Foley has received research support from Biogen. The institution of Dr. Foley has received research support from Novartis. The institution of Dr. Foley has received research support from Octave. The institution of Dr. Foley has received research support from Genentech. The institution of Dr. Foley has received research support from Imstem. The institution of Dr. Foley has received research support from Aegir.
Tobias Monschein	No disclosure on file
Denise F. Chen	Ms. Chen has nothing to disclose.
Guhan Ramamurthy, MD, DM	Dr. Ramamurthy has nothing to disclose.
Jeff Guptill, MD, FAAN	Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has stock in argenx.
Huiam Mubarak, MD	Dr. Mubarak has nothing to disclose.
Tehila Eilam-Stock, PhD	Dr. Eilam-Stock has nothing to disclose.
Theresa B. Sevilis, DO, FAAN	Dr. Sevilis has stock in Moderna.
Lakshmanan Sankaranarayanan, Sr.	Mr. Sankaranarayanan has nothing to disclose.
Minhwan Kim, MD	Mr. Kim has nothing to disclose.
Yin A. Liu, MD	Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Liu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Corey R. Fehnel, MD, FAAN	Dr. Fehnel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XRHealth. The institution of Dr. Fehnel has received research support from National Institute on Aging .
Brian Callaghan, MD, MS, FAAN	Dr. Callaghan has received personal compensation for serving as an employee of University of Michigan. Dr. Callaghan has received personal compensation for serving as an employee of Ann Arbor Veterans Affairs. Dr. Callaghan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dynamed. Dr. Callaghan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. Callaghan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Medico-legal work. Dr. Callaghan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Vaccine Injury Compensation Program. The institution of Dr. Callaghan has received research support from American Academy of Neurology. The institution of Dr. Callaghan has received research support from JDRF. The institution of Dr. Callaghan has received research support from NIDDK. Dr. Callaghan has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Kai Sheng Loh, MBBS	Dr. Loh has nothing to disclose.
Michelle L. Mauermann, MD, FAAN	The institution of Dr. Mauermann has received research support from IONIS. The institution of Dr. Mauermann has received research support from Alnylam. Dr. Mauermann has received publishing royalties from a publication relating to health care.
Kranthi K. Mandava	Mr. Mandava has nothing to disclose.
Ksenija Gorni	Dr. Gorni has received personal compensation for serving as an employee of Hoffman La Roche.
Natte Raksadawan, MD	Dr. Raksadawan has received research support from Faculty of Medicine, KMITL.
Venugopalan Y. Vishnu, MD	The institution of Dr. Vishnu has received research support from Department of Health Research.
Jonathan Kuo, MD	Dr. Kuo has nothing to disclose.
Arif A. Shukralla, MD	Dr. Shukralla has nothing to disclose.
Markus Ponleitner	No disclosure on file
Brian Lee	No disclosure on file
Michele Faulkner, PharmD	Dr. Faulkner has received personal compensation for serving as an employee of Alexion-AstraZeneca Rare Disease. Dr. Faulkner has stock in Alexion-AstraZeneca Rare Disease.
Harini Pavuluri	Harini Pavuluri has nothing to disclose.
Maria Mazurkiewicz-Beldzin	Dr. Mazurkiewicz Beldzin has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen, . Dr. Mazurkiewicz Beldzin has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Mazurkiewicz Beldzin has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche. Dr. Mazurkiewicz Beldzin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Mazurkiewicz Beldzin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Morgan C. Jordan, DO	Dr. Jordan has nothing to disclose.
Swetha Ade, MD	Dr. Ade has nothing to disclose.
Shaweta Khosa, MD	Dr. Khosa has nothing to disclose.
Christine Lebrun Frenay, MD, FAAN	Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique.
Ceren Tozlu	No disclosure on file
Alexandra R. Balshi	Ms. Balshi has nothing to disclose.
Nathalie M. Goemans, MD	Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Goemans has received publishing royalties from a publication relating to health care.
Carlos Guevara Oliva, MD	Dr. Guevara Oliva has nothing to disclose.
Rebecca E. Matthews, MD	Dr. Matthews has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Matthews has received personal compensation in the range of $10,000-$49,999 for serving as a Speaker with Penry Epilepsy Programs.
Naveed Malek, MD	Dr. Malek has nothing to disclose.
Jennifer H. Newman, MD	Dr. Newman has nothing to disclose.
Pranusha Pinna, DO	Dr. Pinna has nothing to disclose.
Ajitesh Ojha, MD	Dr. Ojha has nothing to disclose.
Ima M. Ebong, MD	The institution of Dr. Ebong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB.
Ryan Metzger, PhD	An immediate family member of Dr. Metzger has received personal compensation for serving as an employee of Neurocrine Biosciences. Dr. Metzger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Interpro Bioscience. An immediate family member of Dr. Metzger has stock in Ascendis. An immediate family member of Dr. Metzger has stock in Neurocrine Biosciences.
Samuel W. Terman, MD	Dr. Terman has received research support from American Epilepsy Society. Dr. Terman has received research support from Epilepsy Study Consortium. Dr. Terman has received research support from New York University. Dr. Terman has received personal compensation in the range of $100,000-$499,999 for serving as a clinician scientist trainee for Susan S Spencer award with American Academy of Neurology.
John W. Day, MD, PhD	Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Affinia Therapeutics. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapy. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Muscular Dystrophy Association. The institution of Dr. Day has received research support from Audentes. The institution of Dr. Day has received research support from Novartis Gene Therapy. The institution of Dr. Day has received research support from Biogen. The institution of Dr. Day has received research support from Cytokinetics. The institution of Dr. Day has received research support from Roche/Genentech. The institution of Dr. Day has received research support from Sanofi/Genzyme. The institution of Dr. Day has received research support from Sarepta. The institution of Dr. Day has received research support from Scholar Rock. Dr. Day has received intellectual property interests from a discovery or technology relating to health care.
Robert Hyde, PhD	Dr. Hyde has received personal compensation for serving as an employee of Biogen International GmbH . Dr. Hyde has received stock or an ownership interest from Biogen .
Allan George	Mr. George has nothing to disclose.
Arjuna H. Fernando, MD, MBBS, MRCP	Dr. Fernando has nothing to disclose.
Cynthia Evans	No disclosure on file
Michelle H. Tosin, PhD, RN	Dr. Tosin has nothing to disclose.
Matthew Lustberg	No disclosure on file
Birgit Jaber	No disclosure on file
Goun Je, MD, PhD	Dr. Je has nothing to disclose.
Senaka Bandusena, MD, MBBS, FCCP	Dr. Bandusena has nothing to disclose.
Tejas Ranade, MD	Dr. Ranade has nothing to disclose.
Kimberly O'Neill, MD	Dr. O'Neill has nothing to disclose.
Gabriel D. Pinilla Monsalve, MD, MSc	Dr. Pinilla Monsalve has nothing to disclose.
Dirk Fischer	The institution of Dirk Fischer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann La Roche AG. The institution of Dirk Fischer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann La Roche AG.
Mark Wainwright, MD, PhD, FAAN	Dr. Wainwright has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage Therapeutics.
Amy Kuceyeski, PhD	An immediate family member of Dr. Kuceyeski has received personal compensation for serving as an employee of Heyer Physical Therapy. The institution of Dr. Kuceyeski has received research support from National Institutes of Health. Dr. Kuceyeski has received personal compensation in the range of $500-$4,999 for serving as a Grant Panel Member with Department of Defense.
Fady Mousa-Ibrahim, DO	Dr. Mousa-Ibrahim has nothing to disclose.
Gabriela Trifan, MD	Dr. Trifan has nothing to disclose.
George Nune, MD	Dr. Nune has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Local residental real estate company.
Eric J. Seachrist, MD	Dr. Seachrist has stock in Medtronic. Dr. Seachrist has stock in Pfizer. The institution of Dr. Seachrist has received research support from Bristol Myers Squibb. Dr. Seachrist has a non-compensated relationship as a Topic Group, QOD Committee, and Wellness Program Committee with American Academy of Neurology that is relevant to AAN interests or activities.
Thomas A. Berger, MD	Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
Nicole Rosendale, MD	Dr. Rosendale has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. The institution of Dr. Rosendale has received research support from American Academy of Neurology. The institution of Dr. Rosendale has received research support from NIH StrokeNet Fellowship. Dr. Rosendale has received publishing royalties from a publication relating to health care.
Lee Birnbaum, MD	Dr. Birnbaum has nothing to disclose.
Jennifer Hislop, MD	Dr. Hislop has nothing to disclose.
Sandro Sorbi	Sandro Sorbi has nothing to disclose.
Amanda Avila, MD	Dr. Avila has nothing to disclose.
James F. Sumowski	Mr. Sumowski has nothing to disclose.
Amy Armstrong-Javors, MD	Dr. Armstrong-Javors has nothing to disclose.
Jun Ha Chang	No disclosure on file
Philip De Jager, MD, PhD	Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. De Jager has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Puretech. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. The institution of Dr. De Jager has received research support from roche. The institution of Dr. De Jager has received research support from Biogen. The institution of Dr. De Jager has received research support from puretech.
Basil T. Darras, MD	The institution of Dr. Darras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Darras has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. The institution of Dr. Darras has received research support from National Institutes of Health/National Institute of Neurological Disorders and Stroke,. The institution of Dr. Darras has received research support from Slaney Family Fund for SMA. The institution of Dr. Darras has received research support from Spinal Muscular Atrophy Foundation. The institution of Dr. Darras has received research support from CureSMA. The institution of Dr. Darras has received research support from Working on Walking Fund . The institution of Dr. Darras has received research support from CHERISH, CS2/CS12 . The institution of Dr. Darras has received research support from Biogen for CS11. The institution of Dr. Darras has received research support from AveXis. The institution of Dr. Darras has received research support from Sarepta Pharmaceuticals. The institution of Dr. Darras has received research support from PTC Therapeutics. The institution of Dr. Darras has received research support from Roche. The institution of Dr. Darras has received research support from Santhera. The institution of Dr. Darras has received research support from Scholar Rock. The institution of Dr. Darras has received research support from Fibrogen. The institution of Dr. Darras has received research support from Summit. Dr. Darras has received publishing royalties from a publication relating to health care. Dr. Darras has received publishing royalties from a publication relating to health care.
Janaki Patel, MD	Dr. Patel has nothing to disclose.
Mathura Ravishankar, MD	Dr. Ravishankar has nothing to disclose.
Musab Zorlu, MD	Dr. Zorlu has nothing to disclose.
Achal K. Srivastava, MD, FAAN	Dr. Srivastava has nothing to disclose.
Ayush Agarwal, DM	Dr. Agarwal has nothing to disclose.
Tracy Tholanikunnel, MD	Dr. Tholanikunnel has nothing to disclose.
Emily Casaletto	Miss Casaletto has nothing to disclose.
Sonia Kaur Singh, MD	Dr. Singh has nothing to disclose.
Wolfgang Singer, MD	Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care.
Ajay M. Tunguturi, MD	Dr. Tunguturi has nothing to disclose.
Brett M. Kissela, MD, MS, FAAN	The institution of Dr. Kissela has received research support from NIH/NINDS and NCATS.
Deepti Zutshi, MD, FAAN	Dr. Zutshi has nothing to disclose.
Sarah E. Berini, MD	Dr. Berini has nothing to disclose.
Aaisha Mozumder, MD	Dr. Mozumder has nothing to disclose.
Giulia Giacomucci, MD	Ms. Giacomucci has nothing to disclose.
Jose Biller, MD, FACP, FAHA, FAAN	Dr. Biller has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Biller has received publishing royalties from a publication relating to health care.
Glenn T. Stebbins, PhD	Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS.
Tabitha Karatz	No disclosure on file
Kiran Thakur, MD, FAAN	Dr. Thakur has received personal compensation for serving as an employee of World Health Organization. Dr. Thakur has received personal compensation for serving as an employee of Pan American Health Organization. Dr. Thakur has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Delve Bio. The institution of Dr. Thakur has received research support from Center for Disease Control and Prevention. The institution of Dr. Thakur has received research support from National Institute of Health.
Richard Lee	Mr. Lee has nothing to disclose.
Leigh E. Charvet, PhD	Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
Mikael Cohen	Mikael Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Roche, Merck, Ad scientiam, Novartis, Alexion, BMS.
Ronald Alvarado Dyer, MD	Dr. Alvarado Dyer has nothing to disclose.
Pushpendra N. Renjen, MD	Dr. Renjen has nothing to disclose.
Aracelis Torres	No disclosure on file
Bruce Taylor	Bruce Taylor has nothing to disclose.
Sabeena I. Malik, MD	Dr. Malik has nothing to disclose.
Matthew Rizzo, MD, FAAN	The institution of Dr. Rizzo has received research support from NIH. Dr. Rizzo has a non-compensated relationship as a Chair with ABC that is relevant to AAN interests or activities.
Karen Lundgren	Ms. Lundgren has nothing to disclose.
Valerie Jeanneret Lopez, MD	Dr. Jeanneret Lopez has nothing to disclose.
Ming Lu	No disclosure on file
Kallol K. Set, MD	Dr. Set has nothing to disclose.
Mashina Chomba, MBChB	Dr. Chomba has nothing to disclose.
Maryam J. Syed, MBBS	Dr. Syed has nothing to disclose.
Kaho Onomichi	No disclosure on file
Enrico S. Bertini, MD	Dr. Bertini has received personal compensation for serving as an employee of Bambino Gesu' Children's Resesarch Hospital.
Katherine Park, MD	Dr. Park has nothing to disclose.
Mark A. Mintun, MD	Dr. Mintun has received personal compensation for serving as an employee of Eli Lilly & Co.
Ashalatha Radhakrishnan, Sr., MD	Dr. Radhakrishnan has nothing to disclose.
Jessica Frey, MD	The institution of Dr. Frey has received research support from Tourette Association of America.
Faizan Akram	Mr. Akram has nothing to disclose.
Nataliya Pyatka, MD	Dr. Pyatka has nothing to disclose.
Ayaz M. Khawaja, MD	Dr. Khawaja has nothing to disclose.
Giovanni Baranello	Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AveXis. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AveXis. The institution of Giovanni Baranello has received research support from Great Ormond Street Hospital Charity.
Fawaz Al-Mufti, MD	Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Revalesio .
Kathryn J. Swoboda, MD	Dr. Swoboda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Swoboda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Swoboda has received research support from Biogen.
Heidi N. Beadnall, MD	Dr. Beadnall has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Beadnall has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Beadnall has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Beadnall has received research support from MSBase Foundation.
Fritz Leutmezer	Fritz Leutmezer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Almirall, Biogen, Celgene, Johnson&Johnson, Novartis, Merck, Roche, Sanofi, Teva-Ratiopharm. Fritz Leutmezer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall, Biogen, Celgene, Johnson&Johnson, Novartis, Merck, Roche, Sanofi, Teva-Ratiopharm. Fritz Leutmezer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Almirall, Biogen, Celgene, Johnson&Johnson, Novartis, Merck, Roche, Sanofi, Teva-Ratiopharm. The institution of Fritz Leutmezer has received research support from Biogen, Merck, Novartis, Roche.
Aparna Polavarapu Ramarao, MD	Dr. Polavarapu Ramarao has nothing to disclose.
Angelene Christensen	Ms. Christensen has a non-compensated relationship as a project manager with InterPro Bioscience that is relevant to AAN interests or activities.
Gregory J. Esper, MD, MBA, FAAN	Dr. Esper has stock in NeuroOne Medical Technologies, Inc. Dr. Esper has stock in Focused Cryo, Inc. The institution of an immediate family member of Dr. Esper has received research support from Centers for Disease Control. The institution of Dr. Esper has received research support from Health and Human Services Assistant Secretary for Preparedness and Response. An immediate family member of Dr. Esper has received publishing royalties from a publication relating to health care.
James F. Burke, MD	Dr. Burke has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association/Circulation: Cardiovascular quality and outcomes.
Charchit Gupta, DNB	No disclosure on file
Richard T. Benson, MD, PhD, FAAN	Dr. Benson has received personal compensation in the range of $100,000-$499,999 for serving as a Federal employee with HHS/NIH.
Michael V. Robers, MD	Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Robers has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Robers has received research support from National Multiple Sclerosis Society. The institution of Dr. Robers has received research support from Bristol Myers Squibb Foundation. The institution of Dr. Robers has received research support from Barrow Neurological Foundation.
Laura J. Balcer, MD, MSCE, FAAN	An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia. Dr. Balcer has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for North American Neuro-Ophthalmology Society.
Ioannis Karakis, MD, FAAN	Dr. Karakis has received personal compensation for serving as an employee of Emory University School of Medicine. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Karakis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GSK. Dr. Karakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epitel. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Hill Ward Henderson.
Lisena Hasanaj	Ms. Hasanaj has nothing to disclose.
Michael Chang, DO	Dr. Chang has nothing to disclose.
Mohammad Dibs, MD	Dr. Dibs has nothing to disclose.
Steven Galetta, MD, FAAN	Dr. Galetta has nothing to disclose.
Saman Fatima, MD	Dr. Fatima has nothing to disclose.
Alejandro Vargas, MD, MS	Dr. Vargas has nothing to disclose.
Edward J. Novotny, Jr., MD, FAAN	No disclosure on file
Katherine Buzzard, MBBS, PhD, FRACP	Dr. Buzzard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Buzzard has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Buzzard has received personal compensation in the range of $5,000-$9,999 for serving as a support to attend educational conference with Roche.
Vivek Bhat	Mr. Bhat has nothing to disclose.
Heather Simpson	No disclosure on file
Christianne N. Heck, MD	Dr. Heck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors/TeleDoc. The institution of Dr. Heck has received research support from Neuropace, Inc.
Shrikant Mishra, MD	Dr. Mishra has nothing to disclose.
Joanne M. Wagner, PhD, PT	Dr. Wagner has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Wagner has received personal compensation for serving as an employee of Biogen. Dr. Wagner has stock in Biogen. Dr. Wagner has stock in Xenon Pharmaceuticals.
Bichum Ouyang	No disclosure on file
Srikanth Muppidi, MD, FAAN	Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Becky Schierman	Ms. Schierman has nothing to disclose.
Anjail Sharrief, MD	The institution of Dr. Sharrief has received research support from NIH. The institution of Dr. Sharrief has received research support from University of Houston . Dr. Sharrief has a non-compensated relationship as a Consultant with Abbott that is relevant to AAN interests or activities.
Julian Thomas, MD	Dr. Thomas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Therese Dunne, MD	Dr. Dunne has nothing to disclose.
Jeannette Lechner-Scott, MD, PhD, FRACP	The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for elsevier. The institution of Prof. Lechner-Scott has received research support from Merck. The institution of Prof. Lechner-Scott has received research support from Biogen.
Rohan Rao, MD	The institution of Mr. Rao has received research support from American Brain Tumor Association. The institution of Mr. Rao has received research support from American Academy of Neurology.
Arshdeep Kaur, MD	Dr. Kaur has nothing to disclose.
John Brandsema, MD	Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Fibrogen. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise. The institution of Dr. Brandsema has received research support from Novartis. The institution of Dr. Brandsema has received research support from Biogen. The institution of Dr. Brandsema has received research support from Alexion. The institution of Dr. Brandsema has received research support from CSL Behring. The institution of Dr. Brandsema has received research support from Pfizer. The institution of Dr. Brandsema has received research support from PTC Therapeutics. The institution of Dr. Brandsema has received research support from Sarepta. The institution of an immediate family member of Dr. Brandsema has received research support from Argenx. The institution of Dr. Brandsema has received research support from Astellas. The institution of Dr. Brandsema has received research support from Fibrogen. The institution of Dr. Brandsema has received research support from Genentech. The institution of Dr. Brandsema has received research support from Janssen. The institution of Dr. Brandsema has received research support from Scholar Rock.
Shivanee Sodani, MBBS	Dr. Sodani has nothing to disclose.
Brent Jacobus II, MD	Dr. Jacobus has nothing to disclose.
Michael O. Kinney, MD	Dr. Kinney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Arvelle Therapeutics .
Henry P. Moore, MD	Dr. Moore has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Moore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen Pharma. The institution of Dr. Moore has received research support from Sage Therapeutics. The institution of Dr. Moore has received research support from Bukwang Pharmaceutical. The institution of Dr. Moore has received research support from Neurocrine. The institution of Dr. Moore has received research support from CDHI Foundation. The institution of Dr. Moore has received research support from MODUS Outcomes LLC.
Lauren B. Krupp, MD, FAAN	Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lerhman. Dr. Krupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for medscape. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLive. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Krupp has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Cleveland Clinic. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for MCIC. The institution of Dr. Krupp has received research support from Biogen. The institution of Dr. Krupp has received research support from National Multiple Sclerosis Society. Dr. Krupp has received intellectual property interests from a discovery or technology relating to health care.
Sujani Bandela, MD	Dr. Bandela has nothing to disclose.
Jon A. Karel, MD	Dr. Karel has nothing to disclose.
Mark P. Figgie, Jr., MD	Dr. Figgie has nothing to disclose.
Jennifer Merickel	No disclosure on file
Omotola A. Hope, MD	Dr. Hope has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences.
William Hoffman, MD	The institution of Dr. Hoffman has received research support from United States Air Force. Dr. Hoffman has a non-compensated relationship as a Member with United States Air Force that is relevant to AAN interests or activities.
Katerina Markopoulou, MD, PhD	Dr. Markopoulou has nothing to disclose.
Joshua Chodosh, MD	The institution of Dr. Chodosh has received research support from NIH-NIA. The institution of Dr. Chodosh has received research support from NIH-NIMHD. The institution of Dr. Chodosh has received research support from NIH-NINR. The institution of Dr. Chodosh has received research support from SCAN Health Plan. The institution of Dr. Chodosh has received research support from New York State Department of Health.
Tomas Kalincik	Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Health and Medical Research Council. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MS Research Australia. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for WebMD Global. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BioCSL. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Tomas Kalincik has received research support from Biogen. The institution of Tomas Kalincik has received research support from Novartis. The institution of Tomas Kalincik has received research support from Genzyme. The institution of Tomas Kalincik has received research support from Roche. The institution of Tomas Kalincik has received research support from Celgene. The institution of Tomas Kalincik has received research support from Merck. The institution of Tomas Kalincik has received research support from MSBase Foundation. The institution of Tomas Kalincik has received research support from ARSEP and EDMUS Foundations. The institution of Tomas Kalincik has received research support from MS Research Australia. The institution of Tomas Kalincik has received research support from National Health and Medical Research Council. The institution of Tomas Kalincik has received research support from Australian Research Council. The institution of Tomas Kalincik has received research support from MS Society. The institution of Tomas Kalincik has received research support from Trish Foundation. Tomas Kalincik has a non-compensated relationship as a scientific leadership group vice-chair with MSBase Foundation that is relevant to AAN interests or activities.
Kyra Curtis, MD	Ms. Curtis has nothing to disclose.
Alexandra C. Simpson, MD	Dr. Simpson has nothing to disclose.
Keiko A. Fukuda, MD	Dr. Fukuda has nothing to disclose.
Olga Syritsyna, MD	The institution of Dr. Syritsyna has received research support from NeuroNext.
Salvatore Mazzeo	Mr. Mazzeo has nothing to disclose.
Silvia Bader-Weder, MD	Dr. Bader-Weder has received personal compensation for serving as an employee of F. Hoffmann - La Roche. Dr. Bader-Weder has received stock or an ownership interest from F. Hoffmann - La Roche.
Thien Nguyen, MD	Dr. Nguyen has nothing to disclose.
Bhavesh Trikamji, MD	Dr. Trikamji has nothing to disclose.
Patrick Altmann	The institution of Mr. Altmann has received research support from Quanterix. The institution of Mr. Altmann has received research support from Biogen, Merck, Roche, Sanofi, Teva,. Mr. Altmann has received intellectual property interests from a discovery or technology relating to health care.
Norman Delanty, MD	No disclosure on file
Shiran Paranavitane, MD, MBBS	Dr. Paranavitane has nothing to disclose.
Laurel J. Cherian, MD, FAAN	The institution of Dr. Cherian has received research support from NIH.
Seth N. Levin, MD	Dr. Levin has received personal compensation for serving as an employee of Biogen. Dr. Levin has received stock or an ownership interest from Biogen.
Micky K. Bacchus	Miss Bacchus has nothing to disclose.
Helmut Butzkueven, MD, MBBS	Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis.
Ruba Al-Ramadhani, MD	Dr. Al-Ramadhani has nothing to disclose.
Adalia H. Jun-O'Connell, MD, MBA	Dr. Jun-O'Connell has nothing to disclose.
Austin Mefford	Mr. Mefford has nothing to disclose.
Monica B. Dhakar, MBBS	The institution of Dr. Dhakar has received research support from NIH. The institution of Dr. Dhakar has received research support from UCB Biopharma. The institution of Dr. Dhakar has received research support from Marinus Pharmaceuticals.
Ali E. Kaabi, MD	Dr. Kaabi has nothing to disclose.
Joseph Frazee, DO	Dr. Frazee has nothing to disclose.
Mariana Suarez	No disclosure on file
Aristotle Mante	Aristotle Mante has nothing to disclose.
Graham K. Reid, DO	Dr. Reid has nothing to disclose.
Nicholas Koroneos, DO	Dr. Koroneos has nothing to disclose.
Yingkai Li, MD, PhD	Dr. Li has nothing to disclose.
Patricia Lee, MD	Dr. Lee has nothing to disclose.
Korhan Buyukturkoglu, PhD	Dr. Buyukturkoglu has nothing to disclose.
Tammy T. Pham, MD	Dr. Pham has nothing to disclose.
Colleen L. Schneider	Ms. Schneider has nothing to disclose.
Yujie Wang, MD	Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Wang has received research support from Genentech.
Victoria Leavitt, PhD, FAAN	Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Leavitt has received research support from National Institutes of Health. The institution of Dr. Leavitt has received research support from National Multiple Sclerosis Society. The institution of Dr. Leavitt has received research support from Department of Defense. Dr. Leavitt has received intellectual property interests from a discovery or technology relating to health care.
Sasha Zivkovic, MD, FAAN	Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Zivkovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam .
Benedetta Nacmias	Benedetta Nacmias has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Milena Lobaina, MD	Dr. Lobaina has nothing to disclose.
Laurent Servais	Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. The institution of Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evox. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sysnav. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioHaven. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zentech. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MitoRx. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lupin. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fibrogen. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alltrana. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illumina. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Laurent Servais has received research support from Roche. The institution of Laurent Servais has received research support from Novartis. The institution of Laurent Servais has received research support from Biogen. The institution of Laurent Servais has received research support from Zentech. The institution of Laurent Servais has received research support from BioHaven. The institution of Laurent Servais has received research support from PerkinHalmers. The institution of Laurent Servais has received research support from Scholar Rock.
Amin Marji, MD	Dr. Marji has nothing to disclose.
Angela Aungst	No disclosure on file
Jay L. Liu, DO	Dr. Liu has nothing to disclose.
Kamal R. Chemali, MD	Dr. Chemali has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Chemali has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. The institution of Dr. Chemali has received research support from Sjögren's Foundation. The institution of Dr. Chemali has received research support from NIH.
Nicole Gonzales, MD	The institution of Dr. Gonzales has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Negar Moheb, MD	Dr. Moheb has nothing to disclose.
Lamya Ibrahim, MD, MBBS	Dr. Ibrahim has nothing to disclose.
Munachi N. Okpala, NP	Ms. Okpala has nothing to disclose.
Nirmal Surya, MD, DNB, FAAN	Dr. Surya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB india, Abbot and Esai pharma. Dr. Surya has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbot. Dr. Surya has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ESAI pharma. Dr. Surya has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Movement disorder society.
Janbernd Kirschner	No disclosure on file
Scott D. Newsome, DO, FAAN	Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from The Stiff Person Syndrome Research Foundation. The institution of Dr. Newsome has received research support from Lundbeck. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Caralynn Li, DO	Dr. Li has nothing to disclose.
Lyell K. Jones, MD, FAAN	Dr. Jones has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. Jones has received publishing royalties from a publication relating to health care. Dr. Jones has a non-compensated relationship as a member of the AAN Board of Directors with AAN that is relevant to AAN interests or activities. Dr. Jones has a non-compensated relationship as a member of the Mayo Clinic ACO Board of Directors with Mayo Clinic that is relevant to AAN interests or activities.
Alexandria Cummuta	Ms. Cummuta has nothing to disclose.
Gina Kackloudis, Other	Ms. Kackloudis has received personal compensation for serving as an employee of Happify Health.
Roberta Frigerio, MD	Dr. Frigerio has nothing to disclose.
Claudia A. Chiriboga, MD, FAAN	Dr. Chiriboga has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Chiriboga has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Chiriboga has received research support from Roche. The institution of Dr. Chiriboga has received research support from Avexis/Novartis. The institution of Dr. Chiriboga has received research support from Biogen. The institution of Dr. Chiriboga has received research support from NIH. The institution of Dr. Chiriboga has received research support from Biohaven. The institution of Dr. Chiriboga has received research support from Genentec. Dr. Chiriboga has received publishing royalties from a publication relating to health care.
Yaqub Al Sami, MBBS	Dr. Al Sami has nothing to disclose.
Ahmad Ozair	Mr. Ozair has nothing to disclose.
Derrick Robertson, MD	Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Greenwich Biosciences. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mallinckrodt. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PRIME CME. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McVeigh. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mccumber. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goodis. The institution of Dr. Robertson has received research support from Biogen. The institution of Dr. Robertson has received research support from EMD Serono. The institution of Dr. Robertson has received research support from Jansenn. The institution of Dr. Robertson has received research support from Genentech. The institution of Dr. Robertson has received research support from Patient-Centered Outcomes Research Institute. The institution of Dr. Robertson has received research support from Novartis. The institution of Dr. Robertson has received research support from Sanofi Genzyme. The institution of Dr. Robertson has received research support from TG Therapeutics. The institution of Dr. Robertson has received research support from Prime. The institution of Dr. Robertson has received research support from Greenwich Biosciences. The institution of Dr. Robertson has received research support from Atara Biotherapeutics. The institution of Dr. Robertson has received research support from CorEvitas. The institution of Dr. Robertson has received research support from Anokion. The institution of Dr. Robertson has received research support from UCB Biosciences. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Consortium of Multiple Sclerosis Centers. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Keval D. Shah, MD	Dr. Shah has nothing to disclose.
Jeffrey C. McClean II, MD, FAAN	Dr. McClean has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. McClean has received personal compensation in the range of $0-$499 for serving as a Committee Member with American Academy of Neurology.
Muhammad Bilal Tariq, MBBS	Dr. Tariq has nothing to disclose.
Anjali Mishra	No disclosure on file
Sarah M. Benish, MD, FAAN	Dr. Benish has nothing to disclose.
Amanda Lien	No disclosure on file
Padma V. Hadakasira, MD	Dr. Hadakasira has nothing to disclose.
Badria Munir, MD	Dr. Munir has nothing to disclose.
Sama Elrahi, MD	Ms. Elrahi has nothing to disclose.
Richard S. Finkel, MD, FAAN	Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReveraGen. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Finkel has received research support from AveXis. The institution of Dr. Finkel has received research support from Biogen. The institution of Dr. Finkel has received research support from Capricor. The institution of Dr. Finkel has received research support from Catabasis. The institution of Dr. Finkel has received research support from ReveraGen. The institution of Dr. Finkel has received research support from Roche. The institution of Dr. Finkel has received research support from Scholar Rock. Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. Dr. Finkel has received personal compensation in the range of $0-$499 for serving as a Speaker in workshop with National Academy of Sciences. Dr. Finkel has a non-compensated relationship as a advisor with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Finkel has a non-compensated relationship as a Board Member with EveryLife Foundation that is relevant to AAN interests or activities.
Eduardo E. Benarroch, MD, FAAN	Dr. Benarroch has nothing to disclose.
Daniel M. Oh, MD	Dr. Oh has nothing to disclose.
Konrad Kubicki, MD	Dr. Kubicki has nothing to disclose.
Kate Daniello, MD, FAAN	Dr. Daniello has nothing to disclose.
Elizabeth A. Coon, MD, FAAN	Dr. Coon has nothing to disclose.
Jori Fleisher, MD, MSCE, FAAN	The institution of Dr. Fleisher has received research support from Parkinson's Foundation. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIH/NIA/Emory Roybal Center for Dementia Caregiving Mastery. Dr. Fleisher has received publishing royalties from a publication relating to health care. Dr. Fleisher has received personal compensation in the range of $0-$499 for serving as a Speaker with Parkinson's Foundation. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Lewy Body Dementia Association. Dr. Fleisher has received personal compensation in the range of $0-$499 for serving as a Speaker with Davis Phinney Foundation. Dr. Fleisher has a non-compensated relationship as a Editorial Board Member with AAN Brain & Life Magazine that is relevant to AAN interests or activities.
Muhammad Athar	No disclosure on file
Farman Ali, MD	Dr. Ali has nothing to disclose.
Christine Petit-Frere, MD	Ms. Petit-Frere has nothing to disclose.
Hongxuyang Yu, MD	Dr. Yu has nothing to disclose.